Tell Governor Youngkin to sign the breast cancer bills NOW!

Tell Governor Youngkin to sign HB1828/SB1436 into Law

Governor Youngkin has until March 24th to sign bills that passed in the 2025 General Assembly into law. He has not yet signed HB1828/SB1436. As you know, this legislation will eliminate out-of-pocket costs (co-pays, co-insurance, or deductibles) for follow-up diagnostic or supplemental breast imaging, including diagnostic mammography, ultrasound, and MRIs. This bill applies to all health insurance plans regulated by the Commonwealth of Virginia. For more information about the bill see: FACT SHEET HB1828/SB1436

Please contact Governor Youngkin TODAY and urge him to sign these bills NOW!

ACTION NEEDED NOW!

1) Email Governor Youngkin and Ask Him to Sign HB1828/SB1436 Into Law

Email address: glenn.youngkin@governor.virginia.gov

Subject: Stand with Virginia Women and Sign HB1828/SB1436 into Law

SAMPLE MESSAGE:

Dear Governor Youngkin:

I am a breast cancer survivor/thriver/advocate from [add city/town] writing to respectfully ask you to sign HB182 8/SB1436 into law.

This critical legislation will help ensure earlier detection of breast cancer and save lives by eliminating expensive out-of-pocket costs for medically necessary diagnostic and supplemental breast imaging. I'm asking you to please stand with Virginia women and sign HB1828/SB1435 into law so that no one faces the impossible choice between their health and their finances. [Add something personal about your own experience]

Sincerely,

NAME

TOWN/CITY

THANK YOU!! For questions, contact Kirsta Millar

kirsta@vbcf.org or 804-285-1200 ext. 203.

ICYMI:

General Assembly 2025 Re-Cap

Opportunity to Take Part in Paid Research Interviews

The National Breast Cancer Coalition is partnering with researchers affiliated with Harvard and the London School of Economics on a breast cancer study. The study aims to better understand the views of individuals diagnosed with breast cancer on drug regulatory approval. The study is led by researchers at The London School of Economics (UK) and Harvard Medical School (US). The interview would focus on understanding participants' views on different aspects of cancer drug approval in the United States. No existing knowledge is required. Any information or views collected in the study will be kept anonymous. Find out more HERE

www.vbcf.org | 1-800-345-8223